Robert B. Barrow's most recent trade in Mind Medicine Inc was a trade of 320,000 Common Shares done . Disclosure was reported to the exchange on Feb. 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mind Medicine Inc | Robert B. Barrow | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2026 | 320,000 | 1,098,477 | - | 0 | Common Shares | |
| Mind Medicine Inc | Robert B. Barrow | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.15 per share. | 26 Dec 2025 | 25,791 | 778,477 | - | 13.1 | 339,072 | Common Shares |
| Mind Medicine Inc | Robert B. Barrow | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 9.77 per share. | 25 Sep 2025 | 25,797 | 804,268 | - | 9.8 | 252,037 | Common Shares |
| Mind Medicine Inc | Robert B. Barrow | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.80 per share. | 25 Jun 2025 | 26,491 | 830,065 | - | 6.8 | 180,139 | Common Shares |
| Mind Medicine Inc | Robert B. Barrow | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.74 per share. | 25 Mar 2025 | 21,208 | 856,556 | - | 6.7 | 142,942 | Common Shares |
| Mind Medicine Inc | Robert B. Barrow | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 350,000 | 877,764 | - | 0 | Common Shares | |
| Mind Medicine Inc | B. Robert Barrow | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.43 per share. | 26 Dec 2024 | 19,106 | 526,666 | - | 7.4 | 141,958 | Common Shares |
| Mind Medicine Inc | Robert B. Barrow | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.98 per share. | 25 Sep 2024 | 19,771 | 545,772 | - | 6.0 | 118,231 | Common Shares |
| Mind Medicine Inc | Robert B. Barrow | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.12 per share. | 19 Aug 2024 | 500 | 565,543 | - | 6.1 | 3,060 | Common Shares |
| Mind Medicine Inc | Robert B. Barrow | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.31 per share. | 19 Aug 2024 | 500 | 565,043 | - | 6.3 | 3,155 | Common Shares |
| Mind Medicine Inc | Robert B. Barrow | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 25 Jun 2024 | 15,659 | 564,543 | - | 7.2 | 113,058 | Common Shares |
| Mind Medicine Inc | Robert B. Barrow | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 9.50 per share. | 25 Mar 2024 | 16,519 | 580,202 | - | 9.5 | 156,931 | Common Shares |
| Mind Medicine Inc | Robert B. Barrow | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) |